​

Cingulate (CING) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

CING Stock Forecast

Cingulate (CING) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $10.00, with a high of $10.00 and a low of $10.00. This represents a 96.46% increase from the last price of $5.09.

- $2 $4 $6 $8 $10 High: $10 Avg: $10 Low: $10 Last Closed Price: $5.09

CING Stock Rating

Cingulate stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

CING Price Target Upside V Benchmarks

TypeNameUpside
StockCingulate96.46%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$10.00$10.00$10.00
Last Closing Price$5.09$5.09$5.09
Upside/Downside96.46%96.46%96.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2613---4
May, 2612---3
Apr, 2612---3
Mar, 2612---3
Feb, 2613---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 19, 2026Boobalan PachaiyappanRoth Capital$10.00$4.41126.76%96.46%
May 19, 2025Boobalan PachaiyappanRoth Capital$11.00$3.82187.96%116.11%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 26, 2026H.C. WainwrightBuyBuyhold
May 19, 2026Roth CapitalBuyBuyhold
Aug 08, 2025Roth CapitalBuyBuyhold
May 19, 2025Roth CapitalBuyBuyhold
Jan 30, 2025H.C. WainwrightBuyBuyhold
Nov 20, 2024Maxim GroupBuyupgrade

Financial Forecast

EPS Forecast

$-350 $-270 $-190 $-110 $-30 $50 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-311.99$-10.20$-4.13---
Avg Forecast$-333.21$-10.96$-4.53$-1.39$-0.48$1.31
High Forecast$-333.21$-8.44$-1.88$-0.27$-0.48$1.31
Low Forecast$-333.21$-15.52$-6.64$-2.50$-0.48$1.31
Surprise %-6.37%-6.93%-8.83%---

Revenue Forecast

$5M $9M $13M $17M $21M $25M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$18.65M$7.77M$9.51M$21.01M
High Forecast--$18.65M$7.77M$9.51M$21.01M
Low Forecast--$18.65M$7.77M$9.51M$21.01M
Surprise %------

Net Income Forecast

$-30M $-23M $-16M $-9M $-2M $5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-23.53M$-15.55M$-22.45M---
Avg Forecast$-25.14M$-903.95K$-321.32K$-104.48K$-36.21K$98.82K
High Forecast$-25.14M$-637.04K$-141.93K$-20.37K$-36.21K$98.82K
Low Forecast$-25.14M$-1.17M$-500.71K$-188.59K$-36.21K$98.82K
Surprise %-6.37%1619.76%6886.84%---

CING Forecast FAQ

Is Cingulate stock a buy?

Cingulate stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Cingulate is a favorable investment for most analysts.

What is Cingulate's price target?

Cingulate's price target, set by 6 Wall Street analysts, averages $10 over the next 12 months. The price target range spans from $10 at the low end to $10 at the high end, suggesting a potential 96.46% change from the previous closing price of $5.09.

How does Cingulate stock forecast compare to its benchmarks?

Cingulate's stock forecast shows a 96.46% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Cingulate over the past three months?

  • June 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Cingulate’s EPS forecast?

Cingulate's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.39, marking a -66.34% decrease from the reported $-4.13 in 2025. Estimates for the following years are $-0.48 in 2027, and $1.31 in 2028.

What is Cingulate’s revenue forecast?

Cingulate's average annual revenue forecast for its fiscal year ending in December 2026 is $7.77M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $9.51M, and $21.01M for 2028.

What is Cingulate’s net income forecast?

Cingulate's net income forecast for the fiscal year ending in December 2026 stands at $-104K, representing a -99.53% decrease from the reported $-22.45M in 2025. Projections indicate $-36.209K in 2027, and $98.82K in 2028.